TIENS Group Launches Global Expansion Into New Retail

Food and Healthcare Press Releases Monday November 12, 2018 11:07
TIANJIN, China--12 Nov--PRNewswire/InfoQuest

Leading healthcare company, TIENS Group, has announced their global expansion into the new retail market with the opening of a new flagship TIENS Experience Store in China. Located in the TIENS International Health Industrial Park, the new store features a combination of online and offline consumer experiences through a technology-enhanced approach to new retail business and marketing.

PointsWin, Tiens' brand new e-wallet app plays a core role to connect the blockchain-based customer network. Consumers can use the app to make purchases and earn rewards at any business bearing the TIENS banner. These innovations as a circle are enabling a merger of online and offline retail that the Group has sought to harness through a growing international presence.

TIENS is establishing 110 branches worldwide and the new store will be the icon of the Group's "One Body, Multiple Wings" strategy globally. This includes developing a diverse, integrated healthcare ecosystem spanning physical retail, e-commerce, TCM and medical facilities, as well as educational, tourism, hotel and lifestyle experiences.

"We have always approached development by considering the world from a global perspective," said TIENS Group Chairman Li Jinyuan. "These are especially the regions involved in China's One Belt One Road initiative," he added, noting that a majority of TIENS worldwide branches fall within this zone.

The flagship store will focus on an experience-driven approach to marketing by offering an immersive environment in which customers can explore and discover original health and beauty products.

"Experience marketing is at the cutting-edge of business development trends. We aim to bring our customers an intuitive experience of meticulous care, attentiveness, and beauty," said Board member and General Manager of E-Commerce, Chelsea Li (Li Yue Qi). "The TIENS Experience Store is designed with a calming, aquatic aesthetic that quietly permeates its atmosphere," she continued, adding that "each visitor's experience is like a journey of discovery, and we have carefully arranged our products throughout the store for their benefit."

Through in-depth, immersive customer experiences, this latest development is helping the group transform the concept of brand consumption into a more personalized experience. "The TIENS Experience Store's diverse layout is a concrete representation of the 'One Body, Multiple Wings' global strategy," said Peggy Liu (Liu Yu), Director of the Group's Experience Operations Department.

For more infomation, please refer to http://www.tiens.com/index.php?m=content&c=index&a=show&catid=32&id=85
Photo - https://photos.prnasia.com/prnh/20181109/2295327-1

Latest Press Release

Lipofilling, Expanded Stem Cells Are a Valuable Alternative to Breast Implants

Autologous adipose-derived stem cells (ADSCs) expansion avoids fat resorption, allowing to maintain results achieved after fat grafting 4 years follow-up results of Bioscience Institute Liposkill Plus body shaping approach presented at Las Vegas Easy...

BioNet reports on persistence of antibody responses of recombinant pertussis vaccines in the Lancet Infectious Diseases

Publications report the sustained higher antibody responses of BioNet acellular pertussis vaccines containing genetically inactivated pertussis toxin (PTgen) and the new opportunities to control the resurgence of whooping cough disease BioNet announced...

The Menarini Group Announces Meropenem/vaborbactam European Marketing Authorization

- Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections - The first combination of a carbapenem and a beta-lactamase inhibitor approved for clinical use in...

Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

- FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of first clinical data in BTC - BTC is a group of rare, aggressive...

Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities

- Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles - Evaluation to include...

Related Topics